生技仿製藥規範與公費報銷政策對藥廠經營策略之影響—美國, 歐洲與日本制度之比較分析

J Yamaguchi - 2014 - tdr.lib.ntu.edu.tw
… and to gain first-mover advantage as preferred suppliers for large hospitals and medical
centers, … Medicare Part B was established as part of the Medicare plan‟s coverage for medically …

老人照護服務營運模式初步探索

王建勝, 朱博湧 - 2004 - ir.lib.nycu.edu.tw
… on medical equipments, but also the largest supplier of medical equipments, because, in
fact, almost half of the medical equipment supplies of the world come from The United States. …

專利藥廠與學名藥廠之專利訴訟策略

孫偉棟, 劉尚志 - 2013 - ir.lib.nycu.edu.tw
… The relationship between drug manufacturer and API supplier can be illustrated as a
cook and his foodstuff supplier. API supplier provides raw material for drug manufacturer to “cook” …

[PDF][PDF] 總IIINSURINIJ5FI3INSIRIS

B Foxmon, KN Lohr - rand.org
… were mainly heads of households 61 years of age and older at the time of enrollment,
members of the military, people confined to various institutions, and people eligible for Medicare. …

[引用][C] 参考

S Neiman, L Robinson, CV Slatter, CW Bergeron

[HTML][HTML] 中国流感疫苗预防接种技术指南(2023-2024)

IV TWG, National Immunization Advisory Committee… - 中华流行病学 …, 2023 - html.rhhz.net
… vaccine type or manufacturer-any approved, age-appropriate influenza vaccines can be
used. Combining the influenza epidemic tendency and the prevention and control strategy of …

男性肝細胞中脂肪新生路徑對雄性激素受體活性之調控研究

鄭雅紋 - 2016 - tdr.lib.ntu.edu.tw
… ACLY converts citrate into cytosolic acetyl-CoA, and supplies to ACC to transform to
malonyl… to the manufacturer's instruction of Quikchange site-directed mutagenesis kit (Agilent …

[HTML][HTML] 中国流感疫苗预防接种技术指南(2022-2023)

IV TWG, National Immunization Advisory Committee… - 中华流行病学 …, 2022 - html.rhhz.net
… The Guidelines express no preference for influenza vaccine type or manufacturer-any
approved, age-appropriate influenza vaccines can be used. To minimize harm from influenza and …

[PDF][PDF] 基因資訊作為保險人核保與保險費訂定基礎之妥當性辯證--美國法之經驗與析論

張冠群 - 科技法學評論, 2009 - ir.lib.nycu.edu.tw
2008 年5 月21 日, 時任美國總統之布希簽署[基因資訊無歧視法], 正式禁止保險人及雇用人以基因
測試取得之資訊, 作為歧視性待遇之基礎此後, 保險人不得以基因資訊作為訂定保險費與可保性…